Hostname: page-component-669899f699-g7b4s Total loading time: 0 Render date: 2025-04-29T19:21:32.898Z Has data issue: false hasContentIssue false
  • English
  • Français

Double-blind, placebo-controlled study of once dailyvenlafaxine XR in outpatients with generalized anxiety disorder

Published online by Cambridge University Press:  16 April 2020

J.T. Haskins ,
R. Rudolph  and
L. Aguiar
J.T. Haskins
Affiliation:
For the Venlafaxine XR 214 Study Group, Wyeth-Ayerst Research, Philadelphia, Pennsylvania, USA
R. Rudolph
Affiliation:
For the Venlafaxine XR 214 Study Group, Wyeth-Ayerst Research, Philadelphia, Pennsylvania, USA
L. Aguiar
Affiliation:
For the Venlafaxine XR 214 Study Group, Wyeth-Ayerst Research, Philadelphia, Pennsylvania, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 238s - 239s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.